Donald J Lucas1, John F Sweeney2, Timothy M Pawlik3. 1. Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD. 2. Department of Surgery, Emory University Hospital, Atlanta, GA. 3. Department of Surgery, The Johns Hopkins Hospital, Baltimore, MD. Electronic address: tpawlik1@jhmi.edu.
Abstract
BACKGROUND: Readmission is frequent in hepatopancreatobiliary (HPB) surgery. Medicare began penalizing hospitals recently for excess readmission for specific diagnoses, including some operative procedures. We sought to define the incidence and risk factors for readmission after HPB surgery. STUDY DESIGN: Elective HPB resections were selected from the 2011 American College of Surgeons National Surgical Quality Improvement Program (NSQIP) dataset. Risk factors associated with readmission were assessed using modified Poisson univariate and adjusted regression models. RESULTS: We identified 5,081 patients; 2,980 underwent pancreatic resection and 2,101 had a hepatectomy. Median age was 62 (interquartile range, 52-70), 53% of patients were women; 74% were non-Hispanic white; and 31% were American Society of Anesthesiologists (ASA) class 2, and 64% were ASA class 3. About 75% of cases had a malignant diagnosis on final pathology. Of all these patients, 16.2% were readmitted within 30 days of operation. The strongest risk factors for readmission on multivariable analysis were minor (risk ratio [RR], 3.13, 95% confidence interval [CI], 2.47-3.97; P < .001) and major (RR, 8.45; 95% CI, 7.59-9.40; P < .001) complications after discharge; in contrast, major inpatient complications only had a modest effect on the risk of readmission (RR, 1.29; 95% CI, 1.05-1.58; P < .014). Among all patients who were readmitted, 40% experienced a major complication after discharge, and 83% of patients who had a major outpatient complication were readmitted. CONCLUSION: Outpatient complications were by far the strongest risk factor for readmission. Decreasing complications as well as improving outpatient case management to prevent and treat postdischarge complications hold considerable promise in the efforts to decrease readmission.
BACKGROUND: Readmission is frequent in hepatopancreatobiliary (HPB) surgery. Medicare began penalizing hospitals recently for excess readmission for specific diagnoses, including some operative procedures. We sought to define the incidence and risk factors for readmission after HPB surgery. STUDY DESIGN: Elective HPB resections were selected from the 2011 American College of Surgeons National Surgical Quality Improvement Program (NSQIP) dataset. Risk factors associated with readmission were assessed using modified Poisson univariate and adjusted regression models. RESULTS: We identified 5,081 patients; 2,980 underwent pancreatic resection and 2,101 had a hepatectomy. Median age was 62 (interquartile range, 52-70), 53% of patients were women; 74% were non-Hispanic white; and 31% were American Society of Anesthesiologists (ASA) class 2, and 64% were ASA class 3. About 75% of cases had a malignant diagnosis on final pathology. Of all these patients, 16.2% were readmitted within 30 days of operation. The strongest risk factors for readmission on multivariable analysis were minor (risk ratio [RR], 3.13, 95% confidence interval [CI], 2.47-3.97; P < .001) and major (RR, 8.45; 95% CI, 7.59-9.40; P < .001) complications after discharge; in contrast, major inpatient complications only had a modest effect on the risk of readmission (RR, 1.29; 95% CI, 1.05-1.58; P < .014). Among all patients who were readmitted, 40% experienced a major complication after discharge, and 83% of patients who had a major outpatient complication were readmitted. CONCLUSION:Outpatient complications were by far the strongest risk factor for readmission. Decreasing complications as well as improving outpatient case management to prevent and treat postdischarge complications hold considerable promise in the efforts to decrease readmission.
Authors: Kristoffer W Brudvik; Yoshihiro Mise; Claudius Conrad; Giuseppe Zimmitti; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Am Coll Surg Date: 2015-02-28 Impact factor: 6.113
Authors: Rony Takchi; Gregory A Williams; David Brauer; Tina Stoentcheva; Crystal Wolf; Brooke Van Anne; Cheryl Woolsey; William G Hawkins Journal: Am Surg Date: 2020-01-01 Impact factor: 1.002
Authors: Eliza W Beal; Fabio Bagante; Anghela Paredes; Qinyu Chen; Ozgur Akgul; Katiuscha Merath; Mary E Dillhoff; Jordan M Cloyd; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2018-07-23 Impact factor: 3.452
Authors: Nikolaos Andreatos; Neda Amini; Faiz Gani; Georgios A Margonis; Kazunari Sasaki; Vanessa M Thompson; David J Bentrem; Bruce L Hall; Henry A Pitt; Ana Wilson; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2016-09-12 Impact factor: 3.452
Authors: Yoshihiro Mise; Ryan W Day; Jean-Nicolas Vauthey; Kristoffer W Brudvik; Lilian Schwarz; Laura Prakash; Nathan H Parker; Matthew H G Katz; Claudius Conrad; Jeffrey E Lee; Jason B Fleming; Thomas A Aloia Journal: J Gastrointest Surg Date: 2016-01 Impact factor: 3.452
Authors: Kelvin Allenson; Kea Turner; Brian D Gonzalez; Erin Gurd; Sarah Zhu; Nicole Misner; Alicia Chin; Melissa Adams; Laura Cooper; Diana Nguyen; Samer Naffouje; Diana L Castillo; Maria Kocab; Brian James; Jason Denbo; Jose M Pimiento; Mokenge Malafa; Benjamin D Powers; Jason B Fleming; Daniel A Anaya; Pamela J Hodul Journal: BMC Nutr Date: 2021-12-09
Authors: Rony Takchi; Heidy Cos; Gregory A Williams; Cheryl Woolsey; Chet W Hammill; Ryan C Fields; Steven M Strasberg; William G Hawkins; Dominic E Sanford Journal: HPB (Oxford) Date: 2021-06-16 Impact factor: 3.842
Authors: Anna Lee; Chun Hung Chiu; Mui Wai Amy Cho; Charles David Gomersall; Kit Fai Lee; Yue Sun Cheung; Paul Bo San Lai Journal: BMJ Open Date: 2014-07-10 Impact factor: 2.692